Regístrese
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Most Often Read Most Often Read
Journal Information

Most Often Read

931
Current concepts in acute liver failure
Maximiliano Rovegno, Magdalena Vera, Alex Ruiz, Carlos Benítez
Ann Hepatol. 2019;18:543-52
931
Open access
772
Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)
Juan P. Arab, Juan P. Roblero, Jose Altamirano, Fernando Bessone, Roberta Chaves Araujo, Fatima Higuera-De la Tijera, Juan Carlos Restrepo, Aldo Torre, Alvaro Urzua, Douglas A. Simonetto, Juan G. Abraldes, Nahum Méndez-Sánchez, Fernando Contreras, Michael R. Lucey, Vijay H. Shah, Helena Cortez-Pinto, Ramon Bataller
Ann Hepatol. 2019;18:518-35
772
Open access
577
Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
Sebastião M.B. Duarte, Jose Tadeu Stefano, Claudia P. Oliveira
Ann Hepatol. 2019;18:416-21
577
Open access
551
Endoscopic retrograde cholangiopancreatography versus surgery for choledocholithiasis – A meta-analysis
Fernando C. Schacher, Sofia M. Giongo, Fernanda J.P. Teixeira, Ângelo Z. Mattos
Ann Hepatol. 2019;18:595-600
551
Open access
457
Liver disease in pregnancy: Medical aspects and their implications for mother and child
Carmen Selene García-Romero, Carolina Guzman, Alicia Cervantes, Marco Cerbón
Ann Hepatol. 2019;18:553-62
457
Open access
408
First detection of hepatitis E virus genotype 3 as a common infectious agent in patients with chronic liver damage in Mexico
Oliver Viera-Segura, Mauricio Realpe-Quintero, Arturo Panduro, Sonia Roman, Alexis Jose-Abrego, Karina Gonzalez-Aldaco, Jorge L. Trujillo-Ochoa, Nora A. Fierro
Ann Hepatol. 2019;18:571-7
408
Open access
400
Hepatitis E and chronic liver damage in apparently immunocompetent individuals: Now what?
Santiago Mirazo, Juan Arbiza
Ann Hepatol. 2019;18:539-40
400
Open access
363
Antioxidants benefits in hepatitis C infection in the new DAAs era
Sonia A. Lozano-Sepúlveda, Ana R. Rincón-Sanchez, Ana M. Rivas-Estilla
Ann Hepatol. 2019;18:410-5
363
Open access
334
Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes
Abdulrahman A. Aljumah, Hamad Al-Ashgar, Hind Fallatah, Ali Albenmousa
Ann Hepatol. 2019;18:439-44
334
Open access
315
Hepatitis E in Latin America
Rosa Elena Sarmiento-Silva, Francisco Arenas-Huertero
Ann Hepatol. 2019;18:541-2
315
Open access
296
The basis of liver regeneration: A systems biology approach
Mamatha Bhat, Elisa Pasini, Cristina Baciu, Marc Angeli, Atul Humar, Sonya Macparland, Jordan Feld, Ian McGilvray
Ann Hepatol. 2019;18:422-8
296
Open access
286
Non-alcoholic fatty liver disease and neurological defects
Rita Moretti, Paola Caruso, Silvia Gazzin
Ann Hepatol. 2019;18:563-70
286
Open access
285
Genome-based nutritional strategies to prevent chronic liver disease
Sonia Roman
Ann Hepatol. 2019;18:537-8
285
Open access
279
Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
Cristiane V. Tovo, Cristiane A. Villela-Nogueira, Nathalie C. Leite, Carine L. Panke, Gabriela Z. Port, Sabrina Fernandes, Caroline Buss, Gabriela P. Coral, Ana C. Cardoso, Claudia M. Cravo, Fernanda L. Calçado, Guilherme F.M. Rezende, Frederico C. Ferreira, João M. Araujo-Neto, Renata de M. Perez, Henrique S. Moraes-Coelho, Angelo A. de Mattos
Ann Hepatol. 2019;18:445-9
279
Open access
278
Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment
Alejandra Cano-Paniagua, Pedro Amariles, Nancy Angulo, Margarita Restrepo-Garay
Ann Hepatol. 2019;18:501-7
278
Open access
275
Why, What and Where: 3W in hepatology
Claudio Tiribelli
Ann Hepatol. 2019;18:409
275
Open access
264
Drug and herb-induced liver injury: A critical review of Brazilian cases with proposals for the improvement of causality assessment using RUCAM
Matheus William Becker, Michele John Muller Lunardelli, Cristiane Valle Tovo, Carine Raquel Blatt
Ann Hepatol. 2019;18:742-50
264
Open access
264
The relationship between coagulation disorders and the risk of bleeding in cirrhotic patients
Asma Labidi, Héla Baccouche, Monia Fekih, Sonia Mahjoub, Nadia BenMustapha, Meriem Serghini, Neila BenRomdhane, Jalel Boubaker
Ann Hepatol. 2019;18:627-32
264
Open access
261
Vasoconstrictors in hepatorenal syndrome – A critical review
Ângelo Z. Mattos, Fernando C. Schacher, Angelo A. Mattos
Ann Hepatol. 2019;18:287-90
261
Open access
252
Treatment response in primary biliary cholangitis: The role of autoimmune hepatitis features
Fernando Mané, Hélder Cardoso, Rodrigo Liberal, Susana Lopes, Pedro Pereira, Regina Gonçalves, Guilherme Macedo
Ann Hepatol. 2019;18:488-93
252
Open access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.